BALCO, THG, and Landmark Testosterone Doping Cases
The Clear, Floyd Landis, and How Named Scandals Shaped Anti-Doping
Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not an FDA matter; criminal and sport-governance cases
- WADA
- Cases involving prohibited S1 Anabolic Agents
Reference only. Not medical advice.
What can go wrong
For the marketplace, the named record is a caution against 'undetectable' claims: designer compounds are eventually characterized, stored samples are retro-tested, and IRMS reads synthetic origin regardless of how 'bioidentical' a product is marketed to be. The legal record (federal BALCO prosecutions) shows criminal exposure attaches to manufacture and distribution of these compounds.
This is something to take to a clinician. The Atlas can tell you what is known about balco, thg, and landmark testosterone doping cases in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Factual case studies in steroid doping enforcement. The Bay Area Laboratory Co-operative (BALCO) scandal, exposed in 2003, centered on tetrahydrogestrinone (THG), a designer anabolic steroid nicknamed 'the clear' that was engineered to evade standard testing until a coach anonymously sent a spent syringe to UCLA's anti-doping lab, where Don Catlin's team reverse-engineered and identified it. BALCO implicated multiple elite athletes and led to criminal cases and the 2004 prohormone law. The 2006 Floyd Landis Tour de France case showcased the testosterone-to-epitestosterone ratio and carbon-isotope (IRMS) confirmation in a high-profile testosterone positive.
A used syringe mailed to a lab cracked open BALCO and exposed an undetectable designer steroid called 'the clear.'
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
BALCO worked because THG was a previously unknown molecule not on any screening list, a designer steroid. Detection became possible only after the physical sample (a syringe) let chemists characterize the compound and build an assay; sport then retro-tested stored samples. The Landis case turned on biochemical evidence: an elevated T/E ratio screened the sample as atypical, and gas chromatography/combustion/isotope-ratio mass spectrometry (IRMS) confirmed the testosterone's carbon-isotope signature was consistent with an exogenous (synthetic) source rather than endogenous production.
What these cases proved about detection and law
BALCO demonstrated that an undetectable designer steroid can exist until its structure is known, which is exactly why anti-doping shifted toward sample storage and retrospective testing, and why Congress moved to a similarity-based scheduling approach (culminating in DASCA 2014). The Landis case demonstrated the operational pairing that still anchors testosterone enforcement: a longitudinal/ratio screen (T/E) to flag, then IRMS carbon-isotope analysis to confirm exogenous origin. Together the cases mark the transition from 'list-based' to 'profile-and-isotope-based' anti-doping science.
What people get wrong
Often saidDesigner steroids are truly undetectable
ActuallyOnly until characterized, THG became detectable once a physical sample let chemists build an assay, and stored samples are retro-tested.
Often saidA normal T/E ratio means a clean testosterone test
ActuallyIRMS carbon-isotope analysis can confirm exogenous testosterone independent of the ratio, as the Landis case showed.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- BALCO exposed
- 2003 (federal raid; investigation publicized)
- 'The Clear'
- Tetrahydrogestrinone (THG), a designer anabolic steroid
- Identified by
- Don Catlin / UCLA Olympic Analytical Laboratory from a tip syringe
- Floyd Landis
- 2006 Tour de France winner; stripped after a testosterone positive (T/E and IRMS)
- Legislative effect
- Helped drive the Anabolic Steroid Control Act of 2004
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about BALCO, THG, and Landmark Testosterone Doping Cases. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
THG ('the clear') identification2003
UCLA lab reverse-engineered a designer steroid from a tip sample, enabling an assay
BALCO federal investigation2003-2005
Criminal cases against lab principals; broad athlete implication
Floyd Landis testosterone case2006-2007
T/E screen plus IRMS confirmation; title stripped
Anabolic Steroid Control Act of 20042004
Enacted amid the BALCO/THG era to control prohormones